SCHEMBL31258282

SCHEMBL31258282

Brc1cccc(C2C=COCC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 5/20 0.42
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
RCOR1 Q9UKL0 2/20 0.35
DRD2 P14416 1/20 0.35
DRD1 P21728 1/20 0.35
DRD4 P21917 1/20 0.35
DRD5 P21918 1/20 0.35
DRD3 P35462 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
SIRT2 Q8IXJ6 2/20 0.34
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31258243 0.79 KDM1A (0.39) KDM1AHTR2CHTR2BRCOR1SLC6A2
SCHEMBL8629822 0.78 TSHR (0.37) KDM1AHTR2BKMT2AMEN1CYP2C19
SCHEMBL30954421 0.78 TSHR (0.37) KDM1AHTR2BKMT2AMEN1CYP2C19
SCHEMBL31258231 0.76 HTR2C (0.48) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL31258197 0.71 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3
SCHEMBL20562175 0.71 KDM1A (0.43) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL18312348 0.71 KDM1A (0.43) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL27319350 0.70 KDM1A (0.53) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL31258158 0.69 HTR2C (0.39) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL1893123 0.68 KDM1A (0.47) KDM1AHTR2AHTR2CHTR2BRCOR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119039312-A Method for preparing medical intermediate 3-benzimidazoline coumarin pyranone derivative by catalyzing acid eutectic solvent 南京欣久医药科技有限公司 2024-11-29 CN disclosed